a public good project by the
Synthesis
Company
of California

© 2026

Meenal Sinha | doi.page

0 works0 citations0 h-index

Meenal Sinha

University of California, San Francisco(US)University of Manitoba(CA)University of San Francisco(US)

Publications by Year

Research Areas

Multiple Myeloma Research and Treatments, Bone health and treatments, Bone Tumor Diagnosis and Treatments, Bone Metabolism and Diseases, Cancer Immunotherapy and Biomarkers

Most-Cited Works

→ Epidemiology and Costs of Sepsis in the United States—An Analysis Based on Timing of Diagnosis and Severity Level*(2018)706 cited
→ SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin(2017)294 cited
→ Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma(2021)106 cited
→ Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer(2021)70 cited
→ Isolation of Highly Pure Primary Mouse Alveolar Epithelial Type II Cells by Flow Cytometric Cell Sorting(2016)57 cited
→ A Protective Role for the Fifth Complement Component (C5) in Allergic Airway Disease(2006)53 cited

→ FleA Expression in Aspergillus fumigatus Is Recognized by Fucosylated Structures on Mucins and Macrophages to Prevent Lung Infection(2016)

52 cited

→ Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis(2008)44 cited

→ Inpatient Healthcare Resource Utilization, Costs, and Mortality in Adult Patients with Acute Graft-versus-Host Disease, Including Steroid-Refractory or High-Risk Disease, following Allogeneic Hematopoietic Cell Transplantation(2019)27 cited

→ Determinants of Divergent Adaptive Immune Responses after Airway Sensitization with Ligands of Toll-Like Receptor 5 or Toll-Like Receptor 9(2016)23 cited